Clinical Trials for PharmAbcine

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: PharmAbcine

Clinical Trials (3)

NCT05957081
Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309
PHASE1Not yet recruiting
67 participants
Started: Nov 28, 2023 · Completed: Oct 4, 2028
1 condition3 sponsors4 locations
NCT05953012
Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration
PHASE1Recruiting
36 participants
Started: Jul 20, 2023 · Completed: Oct 30, 2025
1 condition2 sponsors4 locations
NCT04986852
Olinvacimab With Pembrolizumab in Patients With mTNBC
PHASE2Recruiting
30 participants
Started: Sep 30, 2021 · Completed: Aug 30, 2026
1 condition2 sponsors1 location